Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 GDSC1000 pan-cancer AAC -0.055 0.3
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.036 0.3
mRNA PF-184 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA XL-184 GDSC1000 pan-cancer AAC -0.035 0.3
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA lapatinib UHNBreast pan-cancer AAC 0.32 0.3
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.046 0.3
mRNA masitinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.04 0.3
Download CSV